The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Hopkinson Craig C. since 2018.
This trader's CIK number is 1730048.
At the time of last reporting, Hopkinson Craig C. was the EVP R&D, Chief Medical Officer of Alkermes Plc.. (stock ticker symbol ALKS).
Also see all insider trading activities at Alkermes Plc..
Insider Buying | Insider Sales | Option Exercises | |||||
---|---|---|---|---|---|---|---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
2025 | ALKS | 0 | $0 | 450,258 | $15,050,268 | 476,977 | $10,218,211 |
2024 | ALKS | 0 | $0 | 154,188 | $4,777,191 | 112,022 | $1,974,437 |
2023 | ALKS | 0 | $0 | 0 | $0 | 37,730 | $0 |
2022 | ALKS | 0 | $0 | 14,289 | $354,693 | 32,383 | $0 |
2021 | ALKS | 0 | $0 | 29,802 | $591,999 | 21,595 | $0 |
2020 | ALKS | 0 | $0 | 0 | $0 | 11,500 | $0 |
2019 | ALKS | 0 | $0 | 0 | $0 | 4,625 | $0 |
2018 | ALKS | 0 | $0 | 0 | $0 | 1,250 | $0 |
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2025-02-26 | ALKS | Option Ex | 6,866 | .00 | 0 |
2025-02-22 | ALKS | Option Ex | 12,279 | .00 | 0 |
2025-02-23 | ALKS | Option Ex | 7,689 | .00 | 0 |
2025-02-18 | ALKS | Option Ex | 8,896 | .00 | 0 |
2025-02-13 | ALKS | Sale | 144,419 | 35.02 | 5,057,553 |
2025-02-12 | ALKS | Sale | 204,921 | 32.98 | 6,758,294 |
2025-02-13 | ALKS | Option Ex | 144,419 | 28.26 | 4,081,280 |
2025-02-12 | ALKS | Option Ex | 199,196 | 19.68 | 3,921,173 |
2025-01-30 | ALKS | Sale | 100,918 | 32.05 | 3,234,421 |
2025-01-30 | ALKS | Option Ex | 97,632 | 22.70 | 2,215,758 |
2024-12-09 | ALKS | Sale | 61,151 | 32.08 | 1,961,418 |
2024-12-09 | ALKS | Option Ex | 48,997 | 22.70 | 1,111,986 |
2024-12-05 | ALKS | Sale | 9,221 | 31.50 | 290,461 |
2024-12-04 | ALKS | Sale | 14,349 | 30.77 | 441,547 |
2024-11-11 | ALKS | Sale | 58,996 | 30.08 | 1,774,599 |
2024-11-11 | ALKS | Option Ex | 43,058 | 20.03 | 862,451 |
2024-11-06 | ALKS | Sale | 10,471 | 29.53 | 309,166 |
2024-02-23 | ALKS | Option Ex | 7,689 | .00 | 0 |
2024-02-22 | ALKS | Option Ex | 12,278 | .00 | 0 |
2023-02-22 | ALKS | Option Ex | 12,038 | .00 | 0 |
2023-02-18 | ALKS | Option Ex | 8,722 | .00 | 0 |
2023-02-20 | ALKS | Option Ex | 10,095 | .00 | 0 |
2023-02-21 | ALKS | Option Ex | 6,875 | .00 | 0 |
2022-02-23 | ALKS | Sale | 11,983 | 24.76 | 296,651 |
2022-02-22 | ALKS | Option Ex | 12,037 | .00 | 0 |
2022-02-21 | ALKS | Option Ex | 6,875 | .00 | 0 |
2022-02-18 | ALKS | Sale | 2,306 | 25.17 | 58,042 |
2022-02-20 | ALKS | Option Ex | 10,096 | .00 | 0 |
2022-02-16 | ALKS | Option Ex | 3,375 | .00 | 0 |
2021-06-09 | ALKS | Sale | 882 | 24.60 | 21,697 |
2021-06-07 | ALKS | Option Ex | 1,250 | .00 | 0 |
2021-04-15 | ALKS | Sale | 28,920 | 19.72 | 570,302 |
2021-02-20 | ALKS | Option Ex | 10,095 | .00 | 0 |
2021-02-21 | ALKS | Option Ex | 6,875 | .00 | 0 |
2021-02-16 | ALKS | Option Ex | 3,375 | .00 | 0 |
2020-06-07 | ALKS | Option Ex | 1,250 | .00 | 0 |
2020-02-21 | ALKS | Option Ex | 6,875 | .00 | 0 |
2020-02-16 | ALKS | Option Ex | 3,375 | .00 | 0 |
2019-06-07 | ALKS | Option Ex | 1,250 | .00 | 0 |
2019-02-16 | ALKS | Option Ex | 3,375 | .00 | 0 |
2018-06-07 | ALKS | Option Ex | 1,250 | .00 | 0 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Hopkinson Craig C. (EVP R&D, Chief Medical Officer of Alkermes Plc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.